Cefiderocol

Cefiderocol is a powerful antibiotic medicine. It's used to treat serious infections caused by certain types of bacteria, especially those that are resistant to other antibiotics. It works by stopping bacteria from building their protective outer walls. It's typically given through an IV line for serious infections.

Brand names:Fetroja
Medication

What people taking Cefiderocol report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Cefiderocol

What It's For

Cefiderocol, sold in the US as Fetroja, is an intravenous antibiotic used in hospitals for serious infections caused by Gram-negative bacteria, a large group of germs that includes E. coli, Klebsiella, Pseudomonas and Acinetobacter. It is approved for adults 18 and older with complicated urinary tract infections, including kidney infections (pyelonephritis), and with pneumonia that develops in the hospital or while a person is on a breathing machine (ventilator). Its safety and effectiveness in children have not been established. Cefiderocol is a newer antibiotic that can still work against many bacteria that have become resistant to other drugs, including carbapenems, a group of powerful antibiotics often kept for difficult infections. For that reason, US infectious disease guidance from the Infectious Diseases Society of America suggests saving it for infections caused by carbapenem-resistant bacteria, where it is most needed, rather than for infections that older antibiotics can treat. It is one of the preferred options for some of these resistant infections and is used alongside other antibiotics for others. Doctors choose it based on lab tests that identify the bacteria and show which drugs still work against them.

How It Works

Cefiderocol belongs to the cephalosporin family, the same broad family as cephalexin and ceftriaxone. Like other cephalosporins, it kills bacteria by blocking the proteins they use to build their cell wall, so the bacteria break apart. What makes cefiderocol unusual is how it gets inside. Gram-negative bacteria have an extra outer membrane that keeps many antibiotics out, and some resistant strains close off the channels drugs normally pass through. Bacteria need iron to survive, so they actively pull in iron-carrying molecules called siderophores. Cefiderocol binds iron and acts like a siderophore, so the bacteria's own iron transport system carries it through the outer membrane. This helps it reach its target even in some bacteria that resist other antibiotics, though resistance to cefiderocol can still develop.

Dosage & Administration

Cefiderocol is given only in the hospital or another supervised care setting, as an infusion into a vein (IV) that runs over 3 hours. For adults with normal kidney function, it is usually given every 8 hours. Because the kidneys clear the drug, the care team adjusts the dose and timing based on kidney function, including for people on dialysis, and gives it more often to people whose kidneys clear drugs unusually fast. People on intermittent dialysis receive their dose right after the dialysis session. Treatment usually lasts 7 to 14 days, guided by how the person is recovering. There is no pill version, so it is not continued at home by mouth.

Side Effects

Many people receiving cefiderocol are already quite ill, so side effects can be hard to separate from the infection itself. In studies, the more common effects included diarrhea, redness or pain where the IV enters the skin, constipation, rash, nausea, vomiting, headache and yeast infections. Blood tests sometimes showed raised liver enzymes or low potassium or magnesium, which the care team watches for and corrects. In the pneumonia study, a small share of people developed atrial fibrillation, an irregular heart rhythm. Tell the nurse right away about hives, itching, swelling of the face or throat, or trouble breathing during or after an infusion, since these can signal an allergic reaction and the drug should be stopped. Frequent watery or bloody diarrhea, during treatment or even two months or more afterward, can be caused by C. difficile, a bacterial infection of the colon that can follow antibiotic use, and should be reported promptly. Seizures, muscle jerking or new confusion are uncommon but can occur, particularly in people with epilepsy or kidney problems, and need prompt evaluation.

Interactions & Warnings

Cefiderocol should not be given to anyone who has had a severe allergic reaction to it or to other beta-lactam antibiotics, the group that includes penicillins, cephalosporins and carbapenems. People with a penicillin allergy can sometimes react to cephalosporins, so it is important to tell the team about any past antibiotic reaction. In one study of critically ill people with carbapenem-resistant infections, more people died among those treated with cefiderocol than among those given other available antibiotics, mainly in people with hospital pneumonia, bloodstream infections or sepsis. Most deaths were linked to worsening infection or other serious illness, and the reason for the difference has not been established. As a result, the label calls for close monitoring of how a person is responding, and doctors weigh this finding when choosing among options for resistant infections. Cefiderocol is not known to have important interactions with other medicines, but it can make urine dipstick tests falsely show protein, ketones or blood, so positive results may need to be confirmed with another test. There are no studies of cefiderocol in pregnancy, although decades of experience with other cephalosporins have not shown a link to birth defects or miscarriage. Anyone who is pregnant or breastfeeding should let the team know.

What to Expect

Because cefiderocol is used for serious infections, it is usually part of a larger hospital treatment plan that may include other antibiotics, fluids, breathing support or removal of the infection's source. The team typically tracks fever, breathing, blood counts, kidney function and repeat cultures to judge whether the infection is responding, and may adjust the dose if kidney function changes. Improvement often shows over the first several days, but recovery depends heavily on the type of infection, the bacteria involved and how sick the person was to begin with. If the infection does not improve, the team may test whether the bacteria have become resistant and change treatment. Once the course is complete, the antibiotic is usually stopped rather than switched to a long-term medicine, although some people need further antibiotics depending on their infection.

Questions to Ask Your Doctor

  1. 1.Which bacteria are causing this infection, and why is cefiderocol a better choice than other antibiotics for it?
  2. 2.Will cefiderocol be given alone or together with other antibiotics?
  3. 3.How will you tell whether the infection is responding, and what happens if it does not?
  4. 4.How does my kidney function affect the dose, and will it be checked during treatment?
  5. 5.How long will the course last, and will I need any antibiotics after leaving the hospital?

Last reviewed • Oct 2026

Educational content, not medical advice.